stockrow
Friday 6 November 2026
Export YI’s income statement to Excel — free account
111, Inc. Sponsored ADR
YI Healthcare Medical Distribution
111, Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 9.00% from fiscal 2024.
- Revenue
- −29.6%
- EPS
- −113.7%
- Free cash flow
- −185.7%
- Total debt
- +82.5%
Quarter to March 2026, against a year earlier
2.91
0.07
−2.35%
Follow YI
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 7 | 3 | 4 | 3 | 5 | 3 | 4 | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
3.31 | 3.42 | 2.96 | 2.60 | 2.53 | 2.46 | 3.08 | 3.88 | — | — |
P/S ratio |
0.01 | 0.03 | 0.07 | 0.13 | 0.15 | 0.46 | 0.97 | 0.00 | 0.00 | 0.00 |
P/FCF ratio |
2.77 | 3.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(5.61) | (4.01) | (4.56) | (3.08) | (3.14) | (0.71) | (2.02) | 4.38 | (2.55) | 4.47 |
P/Operating CF |
4.99 | (6.43) | (4.85) | 28.93 | (5.81) | (24.18) | (46.19) | (16.50) | 0.00 | 0.00 |
Beneish M-Score |
(3.28) | (3.12) | (2.35) | (3.17) | (0.90) | (1.89) | 0.12 | (1.81) | (4.06) | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.19 | 4.95 | 1.42 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.34 | 5.01 | 1.43 | 0.00 | 0.00 |
EV/Sales |
(0.02) | 0.00 | 0.04 | 0.07 | 0.09 | 0.29 | 0.82 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
112.29 | 16.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(2.24) | 0.13 | (1.46) | (43.59) | (1.69) | (20.10) | (6.31) | 0.00 | 0.00 | 0.00 |
EV/FCF |
(4.71) | 0.27 | (1.11) | (5.85) | (1.45) | (13.54) | (6.31) | 0.00 | 0.00 | 0.00 |
Quick Ratio |
0.45 | 0.40 | 0.44 | 0.52 | 0.63 | 1.09 | 0.99 | 3.61 | 2.39 | 4.28 |
Current Ratio |
1.09 | 1.13 | 1.07 | 1.19 | 1.32 | 1.76 | 1.92 | 4.79 | 3.63 | 5.23 |
Net Debt/EBITDA |
(44.78) | (18.74) | 1.02 | 2.25 | 1.11 | 3.03 | 1.25 | 2.84 | 1.93 | 1.74 |
Debt/Assets |
8.53% | 5.77% | 10.94% | 5.15% | 8.25% | 7.57% | 5.90% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(0.26) | (0.24) | (0.57) | (0.44) | (1.71) | 0.56 | 0.12 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
5.16 | 4.83 | 4.49 | 3.93 | 4.07 | 3.62 | 2.49 | 1.53 | 0.97 | 0.77 |
Operating CF/Net income |
(1.79) | (4.06) | 1.14 | 0.06 | 1.03 | 0.26 | 1.03 | 0.90 | 0.82 | 0.93 |
Capex/Depreciation |
(0.37) | (0.87) | (0.38) | (0.75) | (2.29) | (1.83) | (2.09) | (1.31) | (0.46) | 0.00 |
Interest Coverage |
(0.07) | 0.07 | (17.38) | (27.60) | (117.03) | (53.69) | (136.32) | (58.23) | (4,798.62) | — |
| 9.82% | 10.20% | 77.35% | 145.42% | (547.31%) | (80.68%) | (49.64%) | (313.93%) | 31.08% | 51.65% | |
| (2.73%) | (2.17%) | (11.78%) | (12.12%) | (21.96%) | (20.13%) | (31.46%) | (32.49%) | (25.19%) | (36.72%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (180.08%) | (213.47%) | 0.00% | 0.00% |
Return on Tangible Assets |
(34.53%) | (19.04%) | (176.42%) | (74.55%) | (89.07%) | (35.49%) | (67.71%) | (31.34%) | (45.50%) | (58.13%) |
Average Days of Receivables |
7.55 | 10.47 | 13.11 | 13.20 | 11.88 | 7.26 | 6.03 | 5.84 | 7.76 | 38.23 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.82% |
Selling, General and Administrative Expense of Revenue |
2.61% | 2.67% | 4.50% | 4.91% | 5.80% | 6.43% | 11.74% | 20.09% | 25.38% | 43.94% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 |
Share Based Compensation of Revenue |
0.08% | 0.14% | 1.52% | 1.20% | 1.17% | 0.92% | 1.37% | 2.88% | 1.03% | 0.00% |
Graham Net Nets |
(5.08) | (2.03) | (0.76) | (0.37) | (0.27) | 0.07 | 0.17 | 0.68 | 0.00 | 0.00 |
Graham Number |
16.93 | 15.20 | 38.41 | 34.41 | 28.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(42.27%) | (15.80%) | (40.00%) | (24.26%) | (36.57%) | (11.80%) | (13.37%) | (6.51%) | (4.35%) | (4.35%) |
Free Cash Flow Yield |
36.11% | 33.36% | (59.63%) | (9.84%) | (43.49%) | (4.64%) | (13.36%) | 0.00% | 0.00% | 0.00% |
Revenue per Share |
206.35 | 229.63 | 249.74 | 235.21 | 235.11 | 152.58 | 69.37 | 52.24 | 40.28 | 36.67 |
Operating CF per Share |
1.96 | 4.19 | (7.47) | (0.40) | (13.03) | (2.17) | (8.99) | (10.03) | (8.58) | (16.25) |
Capex per Share |
(0.07) | (0.23) | (0.14) | (0.53) | (1.18) | (0.48) | (0.43) | (0.43) | (0.29) | 0.00 |
Free Cash Flow per Share |
1.89 | 3.96 | (7.61) | (0.93) | (14.21) | (2.65) | (9.42) | (10.46) | (8.86) | (16.25) |
Cash per Share |
10.05 | 8.26 | 11.26 | 16.06 | 17.85 | 30.11 | 12.25 | 32.37 | 19.36 | 25.59 |
Shareholders Equity per Share |
(11.86) | (10.49) | (9.94) | (7.11) | (2.88) | 7.56 | 13.58 | 35.79 | (39.66) | 43.84 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(11.86) | (10.49) | (9.94) | (7.11) | (2.88) | 7.56 | 13.58 | 35.79 | (39.66) | 43.84 |
Free Cash Flow |
16.41 | 34.01 | (64.14) | (7.78) | (117.88) | (21.83) | (77.11) | (52.03) | (31.91) | (58.50) |
Working Capital |
24.48 | 42.07 | 26.52 | 74.05 | 105.41 | 190.50 | 101.70 | 173.45 | 79.99 | 104.85 |
Capital Expenditures |
(0.62) | (2.02) | (1.15) | (4.42) | (9.79) | (3.93) | (3.51) | (2.14) | (1.03) | (1.04) |
Net Current Asset Value |
(113.95) | (109.08) | (105.70) | (93.76) | (77.87) | 38.72 | 92.66 | 172.27 | (147.74) | 104.85 |
EV/EBIT |
112.26 | 16.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
Price to Operating Income |
0.00 | 186.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.56 | 0.52 | 0.63 | 0.84 | 0.34 | 0.32 | 0.39 | 0.56 | 0.87 | 0.52 |
Cash ROIC |
148.15% | 1,173.30% | (109.20%) | (7.74%) | (71.49%) | (6.32%) | (34.26%) | (15.35%) | 43.68% | (23.40%) |
Accounts Receivable Turnover |
38.31 | 29.85 | 28.74 | 29.17 | 44.08 | 73.16 | 83.93 | 71.78 | 17.15 | 9.27 |
Accounts Payable Turnover |
8.07 | 8.09 | 8.28 | 7.87 | 9.86 | 10.52 | 11.49 | 9.74 | 7.85 | 7.11 |
Inventory Turnover |
10.17 | 9.54 | 9.52 | 9.35 | 12.63 | 12.82 | 10.82 | 9.33 | 6.21 | 5.55 |
Average Days of Payables |
39.56 | 46.30 | 41.13 | 50.82 | 41.66 | 49.99 | 42.83 | 46.07 | 53.84 | 42.89 |
Days of Inventory on Hand |
30.80 | 37.31 | 36.75 | 43.16 | 34.66 | 35.70 | 46.87 | 45.76 | 60.53 | 62.39 |
Average Receivables |
46.87 | 66.10 | 73.25 | 67.18 | 44.23 | 17.18 | 6.76 | 3.62 | 8.45 | 14.24 |
Average Payables |
209.61 | 229.80 | 239.82 | 233.65 | 187.96 | 114.16 | 47.35 | 25.12 | 16.73 | 16.89 |
Average Inventory |
166.43 | 195.00 | 208.62 | 196.62 | 146.70 | 93.66 | 50.26 | 26.22 | 21.14 | 21.64 |
Average Assets |
348.28 | 408.50 | 469.37 | 498.65 | 478.74 | 347.57 | 228.11 | 170.14 | 149.14 | 171.57 |
Average Common Equity |
(96.67) | (86.96) | (71.51) | (41.56) | 19.20 | 86.73 | 144.58 | 17.61 | (120.88) | (121.97) |
Columns are period end dates · fundamentals updated 26 Oct 2026